Company: DMAC
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001437749-25-034467
Chunk: 0

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-11-12
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02.

Results of Operations and Financial Condition.

On November 12, 2025, DiaMedica Therapeutics Inc. (the “ Company”) announced its condensed consolidated financial results for the quarter ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and the information set forth therein is incorporated herein by reference and constitutes a part of Item 2.02 of this report.

The information contained in Item 2.02 of this report and Exhibit 99.1 to this report shall not be deemed to be “filed” with the United States Securities and Exchange Commission for purposes of Section 18 of the United States Securities Exchange Act of 1934, as amended (the “ Exchange Act”), and shall not be incorporated by reference into any filings made by the Company under the United States Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.

Item 9.01Financial Statements and Exhibits.